XJPX
7447
Market cap319mUSD
Oct 09, Last price
1,684.00JPY
1D
0.12%
1Q
-3.72%
Jan 2017
-33.99%
IPO
110.50%
Name
Nagaileben Co Ltd
Chart & performance
P/E
19.04
P/S
2.93
EPS
88.44
Div yield, %
5.89%
Shrs. gr., 5y
-1.78%
Rev. gr., 5y
-0.41%
Revenues
17.21b
+1.31%
Net income
2.65b
+2.99%
CFO
3.53b
+61.80%
Dividend
Aug 28, 202670 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nagaileben Co., Ltd. is a Japanese enterprise that manufactures and distributes apparel for the medical industry. Their product range includes specialized clothing for hospitals, clinics, and operating rooms. This company was established in 1915 and has its corporate headquarters located in Tokyo, Japan.
Key people
Ichiro Sawanobori
President, President of Subsidiary, Representative Director · since 2003
Katsuji Asai
Director · since 2025
Nobuhiko Saito
Managing Director, Chief Director of Business Planning · since 2014
Kinya Shintani
Chief Director of Sales, Director · since 2014
Yasuyoshi Yamamoto
Chief Director of Planning, Director · since 2010
Hiroyuki Yamamura
Chief Director of Administration, Director · since 2020
Kota Mishima
Independent Director · since 2016
Emiko Noguchi
Independent Director · since 2022
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑08 | 2025‑08 | 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||